This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 38 of 120 for:    fibromyalgia | Recruiting, Not yet recruiting, Available Studies

Laughter Frequency and Fibromyalgia Symptoms (LAF)

This study is currently recruiting participants.
See Contacts and Locations
Verified November 2016 by Deidre Molchan, Walden University
Sponsor:
Information provided by (Responsible Party):
Deidre Molchan, Walden University
ClinicalTrials.gov Identifier:
NCT02957110
First received: November 2, 2016
Last updated: November 3, 2016
Last verified: November 2016
  Purpose
The purpose of this study is to investigate whether daily laughter frequency is associated with pain intensity and emotional state ratings in individuals who have fibromyalgia syndrome.

Condition Intervention
Fibromyalgia Behavioral: Laughter Frequency

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Relationships Between Laughter Frequency, Pain Perception, and Affect in Fibromyalgia Patients

Resource links provided by NLM:


Further study details as provided by Deidre Molchan, Walden University:

Primary Outcome Measures:
  • Laughter Frequency [ Time Frame: 14 days ]
    Documenting each instance of laughter throughout each day.

  • Pain Ratings [ Time Frame: Three times per day for 14 days ]
    Rating overall pain from 0 to 10, three times daily

  • Emotional State [ Time Frame: Three times per day for 14 days ]
    Rating momentary emotional state three times per day


Estimated Enrollment: 62
Study Start Date: November 2016
Estimated Study Completion Date: August 2017
Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Laughter Frequency
    Relationships between laughter frequency, momentary mood state, and pain will be observed.
Detailed Description:

Participants will be asked to provide (or authorize the researcher to obtain) fibromyalgia diagnosis confirmation from a health care provider.

Initially, participants will complete a demographics form and two screening assessments. Then for 14 days, they will be asked to rate their momentary mood and overall pain levels three times per day (shortly after waking up, around 3:00 p.m., and at about an hour before bedtime). At the same time, they will be asked to log each instance of laughter as it occurs, daily, for 14 days. They will carry the log with them throughout each day in order to document each instance of laughter.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals who have been diagnosed with fibromyalgia syndrome.
Criteria

Inclusion Criteria:

  • Individuals who have fibromyalgia syndrome

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02957110

Contacts
Contact: Deidre G Molchan, M.A. 703-967-0609 deidre.molchan@waldenu.edu

Locations
United States, Minnesota
Walden University Recruiting
Minneapolis, Minnesota, United States, 55401
Contact: Deidre G Molchan, M.A.    703-967-0609    deidre.molchan@waldenu.edu   
Sponsors and Collaborators
Walden University
Investigators
Study Chair: Ellen Levine, PhD Walden University
  More Information

Responsible Party: Deidre Molchan, Doctoral Student, Walden University
ClinicalTrials.gov Identifier: NCT02957110     History of Changes
Other Study ID Numbers: 08-05-16-0146047
Study First Received: November 2, 2016
Last Updated: November 3, 2016
Individual Participant Data  
Plan to Share IPD: No

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on June 27, 2017